Overview
Assay information
Name: | NAb MAb (Neutralizing Antibody (Monoclonal antibodies)) |
Methodology: | Fluorimeter |
Target area: | Adaptive: B-cell and Humoral |
Description
The Neutralization Assay (NAb) is used to measure the ability of antibodies to block entry of virus into target cells. Neutralizing antibodies are considered important because a) pre-existing neutralizing antibodies have been shown to prevent HIV infection through a variety of routes in non-human primates; and b) a rapid secondary antibody response to infection (primed by prior vaccination) may help to control infection and decrease transmission.
Viruses can be classified into tiers based on the ease with which they are neutralized, with Tier 1 being very easy to neutralize and Tier 3 very difficult to neutralize. This classification is based on neutralization assays performed with many donor samples.
Viruses can be classified into tiers based on the ease with which they are neutralized, with Tier 1 being very easy to neutralize and Tier 3 very difficult to neutralize. This classification is based on neutralization assays performed with many donor samples.
With the publicly available data in the CAVD DataSpace we can Learn about studies, products, assays, antibodies, and publications, Find subjects with common characteristics, Plot assay results across studies and years of research, and Compare monoclonal antibodies and their neutralization curves. Data are also accessible via DataSpaceR, our R API.
Sign in to see full information about this assay and to download study data.
Integrated data
and 25 more (show all)